Meiho University Institutional Repository:Item 987654321/3739
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 2878/3796 (76%)
Visitors : 3940978      Online Users : 604
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.meiho.edu.tw/ir/handle/987654321/3739


    Title: Real-world Cost-effectiveness of Drug-eluting Stents vs. Bare-metal Stents for Coronary Heart Disease – A Five-year Follow-up Study
    Authors: Tran1, Hoai Phuong;Wang, Mei-Hua
    Keywords: Anaphylaxis;knowledge;prevention;emergencymanagement
    Date: 2019-09-30
    Issue Date: 2019-09-30T03:25:09Z (UTC)
    Abstract: Objective: To evaluate the cost-effectiveness of using drugeluting stents (DES) compared to bare-metalstents (BMS) for coronary heart disease (CHD).Data sources/study setting: Data were obtained from the National Health Insurance Longitudinal HealthInsurance Database, which contains claims data for 1,000,000 beneficiaries. The data were randomlysampled from all beneficiaries.Study design: A retrospective claims data analysis.Data collection/extraction methods: Patients with stable coronary heart disease who underwent coronarystent implantation from 2007 to 2008 were recruited and followed to the end of 2013. After a 2:1 propen-sity score matched by gender, age, stent number, and the Charlson comorbidity index (CCI), 852 patientswith 568 stents in the BMS group and 284 stents in the DES group were included. The cumulative medicalcosts for both matched groups were estimated with the Kaplan-Meier Sample Average (KMSA), and thenthe incremental cost-effectiveness ratio (ICER) was estimated.Principal findings: The ICER of DES vs. BMS was NT$ 663,000 per cardiovascular death averted and NT$238,394 per cardiovascular death or coronary event averted in five years from the insurer perspective.Conclusion: Percutaneous coronary intervention (PCI) with DES was a more cost-effective strategy thanPCI with BMS for CHD patients during the five-year follow-up.
    Appears in Collections:[Department of Nursing] Papers

    Files in This Item:

    File Description SizeFormat
    王美嬅 article-jcnrc-147_機構典藏 (3).pdf232KbAdobe PDF0View/Open


    All items in MUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback